Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary Epinephrine for Prevention of No-Reflow in STEMI
NCT06847568Phase 3Recruiting
- Sponsor
- Ain Shams University
- Start
- Apr 2024
- Primary completion
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of epinephrine in no-reflow phenomenon, sponsored by Ain Shams University. Started Apr 2024; status: recruiting.
02
Drugs
epinephrine
03
Conditions
no-reflow phenomenon
Beyond the preview
Go deeper on NCT06847568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06847568.